FOXO TECHNOLOGIES INC. Convertible Debt
FOXO TECHNOLOGIES INC. (FOXO) had Convertible Debt of $28.00 million as of 2022-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:ConvertibleDebt · last filed 2023-08-10
- 2022-06-30: Convertible Debt $28.00M.
- 2022-03-31: Convertible Debt $28.00M.
| Period end | Convertible Debt |
|---|---|
| 2022-06-30 | $28.00M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $28.00M 10-Q · filed 2023-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |